120 related articles for article (PubMed ID: 21659761)
1. Angiogenic factors.
Khoury CC; Ziyadeh FN
Contrib Nephrol; 2011; 170():83-92. PubMed ID: 21659761
[TBL] [Abstract][Full Text] [Related]
2. Angiopoietins: vascular growth factors looking for roles in glomeruli.
Woolf AS
Curr Opin Nephrol Hypertens; 2010 Jan; 19(1):20-5. PubMed ID: 19838115
[TBL] [Abstract][Full Text] [Related]
3. Cellular and molecular aspects of diabetic nephropathy; the role of VEGF-A.
Carranza K; Veron D; Cercado A; Bautista N; Pozo W; Tufro A; Veron D
Nefrologia; 2015; 35(2):131-8. PubMed ID: 26300505
[TBL] [Abstract][Full Text] [Related]
4. VEGF and angiopoietins in diabetic glomerulopathy: how far for a new treatment?
Dei Cas A; Gnudi L
Metabolism; 2012 Dec; 61(12):1666-73. PubMed ID: 22554833
[TBL] [Abstract][Full Text] [Related]
5. Real-time PCR study of Ang1, Ang2, Tie-2, VEGF, and KDR expression in human erectile tissue during aging.
Figueiredo A; Cordeiro AL; Tomada N; Tomada I; Rodrigues A; Gouveia A; Neves D
J Sex Med; 2011 May; 8(5):1341-51. PubMed ID: 21091880
[TBL] [Abstract][Full Text] [Related]
6. Vascular endothelial growth factor (VEGF) in the pathogenesis of diabetic nephropathy of type 1 diabetes mellitus.
Mironidou-Tzouveleki M; Tsartsalis S; Tomos C
Curr Drug Targets; 2011 Jan; 12(1):107-14. PubMed ID: 20735351
[TBL] [Abstract][Full Text] [Related]
7. Role of VEGF-A and LRG1 in Abnormal Angiogenesis Associated With Diabetic Nephropathy.
Zhang A; Fang H; Chen J; He L; Chen Y
Front Physiol; 2020; 11():1064. PubMed ID: 32982792
[TBL] [Abstract][Full Text] [Related]
8. Angiopoietins and diabetic nephropathy.
Gnudi L
Diabetologia; 2016 Aug; 59(8):1616-20. PubMed ID: 27207083
[TBL] [Abstract][Full Text] [Related]
9. Vascular endothelial growth factor and diabetic nephropathy.
Chen S; Ziyadeh FN
Curr Diab Rep; 2008 Dec; 8(6):470-6. PubMed ID: 18990304
[TBL] [Abstract][Full Text] [Related]
10. Antiangiogenic endostatin peptide ameliorates renal alterations in the early stage of a type 1 diabetic nephropathy model.
Ichinose K; Maeshima Y; Yamamoto Y; Kitayama H; Takazawa Y; Hirokoshi K; Sugiyama H; Yamasaki Y; Eguchi K; Makino H
Diabetes; 2005 Oct; 54(10):2891-903. PubMed ID: 16186390
[TBL] [Abstract][Full Text] [Related]
11. Angiotensin AT(1) and AT(2) receptors differentially regulate angiopoietin-2 and vascular endothelial growth factor expression and angiogenesis by modulating heparin binding-epidermal growth factor (EGF)-mediated EGF receptor transactivation.
Fujiyama S; Matsubara H; Nozawa Y; Maruyama K; Mori Y; Tsutsumi Y; Masaki H; Uchiyama Y; Koyama Y; Nose A; Iba O; Tateishi E; Ogata N; Jyo N; Higashiyama S; Iwasaka T
Circ Res; 2001 Jan; 88(1):22-9. PubMed ID: 11139469
[TBL] [Abstract][Full Text] [Related]
12. Effects of high glucose and TGF-beta1 on the expression of collagen IV and vascular endothelial growth factor in mouse podocytes.
Iglesias-de la Cruz MC; Ziyadeh FN; Isono M; Kouahou M; Han DC; Kalluri R; Mundel P; Chen S
Kidney Int; 2002 Sep; 62(3):901-13. PubMed ID: 12164872
[TBL] [Abstract][Full Text] [Related]
13. Tie2 receptor ligands, angiopoietin-1 and angiopoietin-2, modulate VEGF-induced postnatal neovascularization.
Asahara T; Chen D; Takahashi T; Fujikawa K; Kearney M; Magner M; Yancopoulos GD; Isner JM
Circ Res; 1998 Aug; 83(3):233-40. PubMed ID: 9710115
[TBL] [Abstract][Full Text] [Related]
14. Antiangiogenic Therapy for Diabetic Nephropathy.
Tanabe K; Maeshima Y; Sato Y; Wada J
Biomed Res Int; 2017; 2017():5724069. PubMed ID: 28835895
[TBL] [Abstract][Full Text] [Related]
15. Different roles for TGF-beta and VEGF in the pathogenesis of the cardinal features of diabetic nephropathy.
Ziyadeh FN
Diabetes Res Clin Pract; 2008 Nov; 82 Suppl 1():S38-41. PubMed ID: 18842317
[TBL] [Abstract][Full Text] [Related]
16. The VEGF-A inhibitor sFLT-1 improves renal function by reducing endothelial activation and inflammation in a mouse model of type 1 diabetes.
Bus P; Scharpfenecker M; Van Der Wilk P; Wolterbeek R; Bruijn JA; Baelde HJ
Diabetologia; 2017 Sep; 60(9):1813-1821. PubMed ID: 28620823
[TBL] [Abstract][Full Text] [Related]
17. Autocrine VEGF-VEGF-R loop on podocytes during glomerulonephritis in humans.
Hohenstein B; Colin M; Foellmer C; Amann KU; Brekken RA; Daniel C; Hugo CP
Nephrol Dial Transplant; 2010 Oct; 25(10):3170-80. PubMed ID: 20395257
[TBL] [Abstract][Full Text] [Related]
18. VEGF and angiopoietins promote inflammatory cell recruitment and mature blood vessel formation in murine sponge/Matrigel model.
Sinnathamby T; Yun J; Clavet-Lanthier MÉ; Cheong C; Sirois MG
J Cell Biochem; 2015 Jan; 116(1):45-57. PubMed ID: 25145474
[TBL] [Abstract][Full Text] [Related]
19. [Non-angiogenic functions of vascular endothelial growth factor].
Xiong Y; Han XF; Luo JC
Sheng Li Ke Xue Jin Zhan; 2011 Feb; 42(1):6-10. PubMed ID: 21595180
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of VEGF and angiopoietin 2: a key to high vascularity of hepatocellular carcinoma?
Moon WS; Rhyu KH; Kang MJ; Lee DG; Yu HC; Yeum JH; Koh GY; Tarnawski AS
Mod Pathol; 2003 Jun; 16(6):552-7. PubMed ID: 12808060
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
